At the recent American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois, Dr. Ash Alpert, a postdoctoral fellow in health services research at Brown University, presented two posters regarding the associations between violence and cancer risk factors for transgender and cisgender people. In this follow-up interview with Oncology Data Advisor, Dr. Alpert delves further into the implications of these two studies' results and shares how their ongoing research in this field seeks to improve the care of transgender people in the health care setting.  

Research has shown that Black American patients with multiple myeloma experience significant disparities in treatment patterns and outcomes compared with White patients. In this interview, Oncology Data Advisor editorial board member Dr. Rahul Banerjee speaks with Dr. Samer Al Hadidi, Assistant Professor at the University of Arkansas Medical School and a leading researcher in the field of multiple myeloma treatment disparities. Dr. Al Hadidi explains the differences in disease biology and treatment outcomes experienced by Black patients and shares solutions for closing this gap and ensuring equal access to care for all patients with multiple myeloma.  

At the recent Oncology Nursing Society (ONS) Congress in Anaheim, California, Dr. Mateo Banegas of the University of California, San Diego (UCSD) gave a presentation about the financial toxicity of cancer care, particularly during the COVID-19 pandemic. In this interview with Oncology Data Advisor, Dr. Banegas shares additional advice for members of the cancer care team on how to engage in conversations about financial costs and well-being with their patients.  

At the recent Oncology Nursing Society (ONS) Congress in Anaheim, California, Janet Rowe, RN, and Lisa Vigil Schattinger, MSN, RN, gave a presentation about medical aid in dying and the nurse's role in supporting their terminally ill patients' rights to autonomous decision-making. In this interview with Oncology Data Advisor, Ms. Rowe and Ms. Vigil Schattinger discuss their own experiences with medical aid in dying, explain their work to spread awareness and provide education to the community, and share additional advice for nurses on how to engage patients and families in meaningful conversations about this important issue.  

 At the recent 47th Annual Oncology Nursing Society (ONS) Congress in Anaheim, California, Dr. Nada Lukkahatai of Johns Hopkins School of Nursing gave a presentation about symptom science and her research regarding nonpharmacological interventions to reduce symptom burden. In this interview with Oncology Data Advisor, Dr. Lukkahatai further delves into this research and explains the future of personalized interventions and biomarkers studies for symptom management.

In honor of Oncology Nursing Month in May, Oncology Data Advisor is celebrating the stories of these essential members of the cancer care team. For this interview, editorial board member Maria Badillo, MSN, RN, OCN^®, CCRP, speaks with Diane Barber, PhD, ANP-BC, AOCNP^®, FAAN, Manager of Advanced Practice Providers at MD Anderson Cancer Center. Dr. Barber explains the importance of building a diverse nursing work force and shares ways to spread awareness about the opportunities that a career in nursing can offer.  

In honor of Oncology Nursing Month in May, Oncology Data Advisor is celebrating the stories of these essential members of the cancer care team. For this interview, editorial board member Maria Badillo, MSN, RN, OCN^®, CCRP, speaks with Doyle Bosque, RN, Director of Nursing Research Programs at MD Anderson Cancer Center. Mr. Bosque explains the role that he plays in the oversight of clinical trials and shares the exciting opportunities that a career in research nursing can offer. 

In honor of Oncology Nursing Month in May, Oncology Data Advisor is celebrating the stories of these essential members of the cancer care team. For this interview, editorial board member Maria Badillo, MSN, RN, OCN^®, CCRP, speaks with Sherry Adkins, MSN, ANP-C, Advanced Practice Provider Supervisor at MD Anderson Cancer Center, about her groundbreaking research in the development of chimeric antigen (CAR) T-cell therapies and the critical role that oncology nurses play in caring for patients receiving this novel therapeutic strategy.  

Recently, Oncology Data Advisor spoke with Dr. Shaheer Khan, an Assistant Professor of Medicine at Columbia University Irving Medical Center, in honor of Skin Cancer Awareness Month. Dr. Khan shares the promising results of two recent trials of cemiplimab and pembrolizumab for cutaneous squamous cell carcinoma, explains future directions in the treatment of patients who are ineligible for immunotherapy, and offers advice for members of the multidisciplinary cancer care team who are treating patients with this disease.  

For patients with testicular cancer, planning is necessary to ensure that patients feel prepared regarding the implications of their disease in the years after they finish treatment. In this interview in honor of Testicular Cancer Awareness Month, Dr. Katie Murray, Assistant Professor at the University of Missouri Department of Surgery-Urology, shares advice for members of the cancer care team on how to counsel their patients on planning for life after testicular cancer.